<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139643">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01283087</url>
  </required_header>
  <id_info>
    <org_study_id>400229</org_study_id>
    <nct_id>NCT01283087</nct_id>
  </id_info>
  <brief_title>Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS</brief_title>
  <official_title>Spinal Anesthesia Using Lidocaine and Sufentanil and TNS (=Transient Neurological Symptoms)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vestre Viken Ringerike Sykehus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vestre Viken Ringerike Sykehus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out whether patients receiving spinal anesthesia
      containing lidocaine and sufentanil get transient neurological symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Symptoms of transient neurological symptoms</measure>
    <time_frame>5 days</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Transient Neurologic Symptoms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are submitted for surgery at a local hospital and where spinal anesthesia is
        indicated.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults over the age of eighteen years

        Exclusion Criteria:

          -  patient refuse spinal anesthesia

          -  spinal anesthesia is contraindicated

          -  pregnancy

          -  patient is incapable of giving consent

          -  diabetes

          -  neurological disorders

          -  chronic pain

          -  chronic use of analgesics

          -  spinal anesthesia within five days before the actual surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>halfdan Aas, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Vestre Viken HF</affiliation>
  </overall_official>
  <overall_official>
    <last_name>halfdan Aas, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>VestreViken HF</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Britt-Marie Berling, MD, PhD</last_name>
    <phone>+4732116000</phone>
    <email>britt-marie.berling@vestreviken.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ringerike Sykehus</name>
      <address>
        <city>Hønefoss</city>
        <zip>No 3501</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Britt-Marie Berling, MD, PhD</last_name>
      <phone>+4732116000</phone>
      <email>britt-marie.berling@vestreviken.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vestre Viken HF Ringerike Sykehus</name>
      <address>
        <city>Hønefoss</city>
        <zip>NO-3510</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Britt-Marie Berling, MD, PhD</last_name>
      <phone>+4732116000</phone>
      <email>britt-marie.berling@vestreviken.no</email>
    </contact>
    <investigator>
      <last_name>Britt-Marie Berling, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 3, 2015</lastchanged_date>
  <firstreceived_date>January 21, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vestre Viken Ringerike Sykehus</investigator_affiliation>
    <investigator_full_name>Britt-Marie Berling</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>TNS</keyword>
  <keyword>Spinal anesthesia</keyword>
  <keyword>Lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neurologic Manifestations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
